Welcome to our dedicated page for Xencor SEC filings (Ticker: XNCR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Xencor's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Xencor's regulatory disclosures and financial reporting.
Xencor Inc director Todd E. Simpson received new equity awards as part of his compensation. On June 16, 2026, he was granted 10,302 shares of Common Stock in the form of restricted stock units, which will fully vest on the first anniversary of the grant date.
On the same date, he also received a stock option covering 20,604 shares of Common Stock at an exercise price of $12.20 per share. These option shares vest in equal monthly installments over one year beginning on the one-month anniversary of June 16, 2026, becoming fully vested on June 16, 2027. Following these awards, Simpson directly holds 23,988 shares of Common Stock and 20,604 stock options.
Deshaies Raymond Joseph reported acquisition or exercise transactions in this Form 4 filing.
Xencor Inc director Raymond Joseph Deshaies reported equity compensation grants. He received 10,302 shares of common stock in the form of restricted stock units that fully vest on the first anniversary of the June 16, 2026 grant. He was also granted options for 20,604 shares at $12.20 per share, vesting in equal monthly installments over one year and fully vesting on June 16, 2027, with expiration on June 15, 2036. Following these awards, he holds 10,302 common shares and 20,604 stock options directly.
Xencor Inc director Ellen Feigal reported an open-market sale of 6,843 shares of Common Stock at $13.06 per share. The transaction was executed on June 18, 2026 pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on June 26, 2025. Following this sale, Feigal holds 12,340 shares directly.
Xencor, Inc. held its 2026 Annual Meeting of Stockholders, with 63,939,410 common shares present or represented by proxy, equal to approximately 86.26% of the 74,127,372 shares outstanding and entitled to vote as of April 17, 2026.
Stockholders elected nine directors to serve until the 2027 Annual Meeting and ratified KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. They also approved an amendment and restatement of the 2023 Equity Incentive Plan, increasing authorized shares reserved for issuance by 4,000,000 shares, and approved on an advisory, non-binding basis the compensation of the company’s named executive officers.
Xencor Inc director Kevin Charles Gorman reported an open-market sale of 7,527 shares of Xencor common stock. The shares were sold at an average price of $12.31 per share. This trade was executed under a 10b5-1 trading plan adopted on June 27, 2025. Following the sale, Gorman directly holds 11,378 Xencor shares.
Xencor Inc director Kurt A. Gustafson reported an open-market sale of company stock. He sold 5,474 shares of Common Stock at a price of $12.31 per share. After this transaction, he directly holds 14,709 Xencor shares. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person.
Xencor Inc director Richard J. Ranieri reported an open-market sale of company stock. On June 15, 2026, he sold 5,474 shares of Common Stock at an average price of $12.31 per share under a pre-arranged Rule 10b5-1 trading plan adopted on June 26, 2025. Following this transaction, he directly holds 13,709 shares.
Xencor Inc director Alan Bruce Montgomery reported an open-market sale of Xencor common stock. On June 15, 2026, he sold 5,064 shares of Common Stock at $12.31 per share. After this transaction, he directly owned 15,547 shares of Xencor common stock.
The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 4, 2026, indicating the timing of the trade was set in advance rather than decided spontaneously.